Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
DRD2 antagonist
DRUG CLASS:
DRD2 antagonist
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
ONC206 (0)
olanzapine (0)
ONC206 (0)
olanzapine (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
MGMT unmethylation
Glioblastoma
MGMT unmethylation
Glioblastoma
Sensitive: C3 – Early Trials
Sensitive
:
C3
Sensitive: C3 – Early Trials
Sensitive
:
C3
HER-2 positive
HER2 Positive Breast Cancer
HER-2 positive
HER2 Positive Breast Cancer
Sensitive: D – Preclinical
Sensitive
:
D
Sensitive: D – Preclinical
Sensitive
:
D
TLR9 expression
Solid Tumor
TLR9 expression
Solid Tumor
Sensitive: D – Preclinical
Sensitive
:
D
Sensitive: D – Preclinical
Sensitive
:
D
EGFR T790M
Non Small Cell Lung Cancer
EGFR T790M
Non Small Cell Lung Cancer
Sensitive: D – Preclinical
Sensitive
:
D
Sensitive: D – Preclinical
Sensitive
:
D
EGFR exon 19 deletion
Non Small Cell Lung Cancer
EGFR exon 19 deletion
Non Small Cell Lung Cancer
Sensitive: D – Preclinical
Sensitive
:
D
Sensitive: D – Preclinical
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login